Glow 70mg

GLOW 70mg is a multi-peptide research blend formulated for controlled laboratory investigation of extracellular-matrix biology and cellular signalling pathways. It contains BPC-157, TB-500 and GHK-Cu, each individually characterised in preclinical research, and is supplied as a combined laboratory reference material.

Because GLOW is a formulation containing multiple peptide constituents, researchers should distinguish between research involving the blend as a whole and research involving any one constituent independently. A combined formulation can produce experimental observations that cannot necessarily be attributed to a single component without an appropriate study design or comparator.

It is suited to research programmes examining extracellular-matrix and fibroblast biology and associated cellular signalling.

The 70mg presentation provides a defined quantity for laboratory procurement. Researchers should review the current product page and applicable batch documentation to confirm the exact formulation, specifications and analytical information.

Each batch is supplied with a Certificate of Analysis (COA) from independent third-party testing, covering HPLC purity and mass-spectrometry identity. Researchers should retain the relevant COA and batch information in their experimental records where applicable.

GLOW 70mg is for laboratory research use only. It is not a medicinal product, is not licensed by the MHRA and is not intended for human or veterinary use, diagnosis, treatment or self-administration. Sold only to qualified researchers aged 18 or over.